Cargando…

Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study

BACKGROUND: Currently, the effect of the 2022 nationwide coronavirus disease 2019 (COVID-19) wave on the perioperative prognosis of surgical patients in China is unclear. Thus, we aimed to explore its influence on postoperative morbidity and mortality in surgical patients. METHODS: An ambispective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lini, Zheng, Ziyu, Zhu, Shouqiang, Luo, Gang, Gao, Baobao, Ma, Yumei, Xu, Shuai, Dong, Hailong, Lei, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344551/
https://www.ncbi.nlm.nih.gov/pubmed/37310058
http://dx.doi.org/10.1097/CM9.0000000000002724
_version_ 1785072888586436608
author Wang, Lini
Zheng, Ziyu
Zhu, Shouqiang
Luo, Gang
Gao, Baobao
Ma, Yumei
Xu, Shuai
Dong, Hailong
Lei, Chong
author_facet Wang, Lini
Zheng, Ziyu
Zhu, Shouqiang
Luo, Gang
Gao, Baobao
Ma, Yumei
Xu, Shuai
Dong, Hailong
Lei, Chong
author_sort Wang, Lini
collection PubMed
description BACKGROUND: Currently, the effect of the 2022 nationwide coronavirus disease 2019 (COVID-19) wave on the perioperative prognosis of surgical patients in China is unclear. Thus, we aimed to explore its influence on postoperative morbidity and mortality in surgical patients. METHODS: An ambispective cohort study was conducted at Xijing Hospital, China. We collected 10-day time-series data from December 29 until January 7 for the 2018–2022 period. The primary outcome was major postoperative complications (Clavien–Dindo class III–V). The association between COVID-19 exposure and postoperative prognosis was explored by comparing consecutive 5-year data at the population level and by comparing patients with and without COVID-19 exposure at the patient level. RESULTS: The entire cohort consisted of 3350 patients (age: 48.5 ± 19.2 years), including 1759 females (52.5%). Overall, 961 (28.7%) underwent emergency surgery, and 553 (16.5%) had COVID-19 exposure (from the 2022 cohort). At the population level, major postoperative complications occurred in 5.9% (42/707), 5.7% (53/935), 5.1% (46/901), 9.4% (11/117), and 22.0% (152/690) patients in the 2018–2022 cohorts, respectively. After adjusting for potential confounding factors, the 2022 cohort (80% patients with COVID-19 history) had a significantly higher postoperative major complication risk than did the 2018 cohort (adjusted risk difference [aRD], 14.9% (95% confidence interval [CI], 11.5–18.4%); adjusted odds ratio [aOR], 8.19 (95% CI, 5.24–12.81)). At the patient level, the incidence of major postoperative complications was significantly greater in patients with (24.6%, 136/553) than that in patients without COVID-19 history (6.0% [168/2797]; aRD, 17.8% [95% CI, 13.6–22.1%]; aOR, 7.89 [95% CI, 5.76–10.83]). Secondary outcomes of postoperative pulmonary complications were consistent with primary findings. These findings were verified through sensitivity analyses using time-series data projections and propensity score matching. CONCLUSION: Based on a single-center observation, patients with recent COVID-19 exposure were likely to have a high incidence of major postoperative complications. REGISTRATION: NCT05677815 at https://clinicaltrials.gov/.
format Online
Article
Text
id pubmed-10344551
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103445512023-07-20 Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study Wang, Lini Zheng, Ziyu Zhu, Shouqiang Luo, Gang Gao, Baobao Ma, Yumei Xu, Shuai Dong, Hailong Lei, Chong Chin Med J (Engl) Original Article BACKGROUND: Currently, the effect of the 2022 nationwide coronavirus disease 2019 (COVID-19) wave on the perioperative prognosis of surgical patients in China is unclear. Thus, we aimed to explore its influence on postoperative morbidity and mortality in surgical patients. METHODS: An ambispective cohort study was conducted at Xijing Hospital, China. We collected 10-day time-series data from December 29 until January 7 for the 2018–2022 period. The primary outcome was major postoperative complications (Clavien–Dindo class III–V). The association between COVID-19 exposure and postoperative prognosis was explored by comparing consecutive 5-year data at the population level and by comparing patients with and without COVID-19 exposure at the patient level. RESULTS: The entire cohort consisted of 3350 patients (age: 48.5 ± 19.2 years), including 1759 females (52.5%). Overall, 961 (28.7%) underwent emergency surgery, and 553 (16.5%) had COVID-19 exposure (from the 2022 cohort). At the population level, major postoperative complications occurred in 5.9% (42/707), 5.7% (53/935), 5.1% (46/901), 9.4% (11/117), and 22.0% (152/690) patients in the 2018–2022 cohorts, respectively. After adjusting for potential confounding factors, the 2022 cohort (80% patients with COVID-19 history) had a significantly higher postoperative major complication risk than did the 2018 cohort (adjusted risk difference [aRD], 14.9% (95% confidence interval [CI], 11.5–18.4%); adjusted odds ratio [aOR], 8.19 (95% CI, 5.24–12.81)). At the patient level, the incidence of major postoperative complications was significantly greater in patients with (24.6%, 136/553) than that in patients without COVID-19 history (6.0% [168/2797]; aRD, 17.8% [95% CI, 13.6–22.1%]; aOR, 7.89 [95% CI, 5.76–10.83]). Secondary outcomes of postoperative pulmonary complications were consistent with primary findings. These findings were verified through sensitivity analyses using time-series data projections and propensity score matching. CONCLUSION: Based on a single-center observation, patients with recent COVID-19 exposure were likely to have a high incidence of major postoperative complications. REGISTRATION: NCT05677815 at https://clinicaltrials.gov/. Lippincott Williams & Wilkins 2023-06-15 2023-07-20 /pmc/articles/PMC10344551/ /pubmed/37310058 http://dx.doi.org/10.1097/CM9.0000000000002724 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Wang, Lini
Zheng, Ziyu
Zhu, Shouqiang
Luo, Gang
Gao, Baobao
Ma, Yumei
Xu, Shuai
Dong, Hailong
Lei, Chong
Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title_full Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title_fullStr Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title_full_unstemmed Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title_short Changes in early postoperative outcomes and complications observed in a single center during the 2022 COVID-19 pandemic wave in China: A single-center ambispective cohort study
title_sort changes in early postoperative outcomes and complications observed in a single center during the 2022 covid-19 pandemic wave in china: a single-center ambispective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344551/
https://www.ncbi.nlm.nih.gov/pubmed/37310058
http://dx.doi.org/10.1097/CM9.0000000000002724
work_keys_str_mv AT wanglini changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT zhengziyu changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT zhushouqiang changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT luogang changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT gaobaobao changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT mayumei changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT xushuai changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT donghailong changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy
AT leichong changesinearlypostoperativeoutcomesandcomplicationsobservedinasinglecenterduringthe2022covid19pandemicwaveinchinaasinglecenterambispectivecohortstudy